MedTrace Logo

The Relationship Among, Serum Uric Acid, Left Ventricular Hypertrophy and Metabolic Syndrome

NCT03473951 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 18000

Last updated 2020-06-09

No results posted yet for this study

Summary

Hyperuricemia is associated with the prevalence of metabolic syndrome and cardiovascular risks in diverse of the population. Whether the dose-response effects on the prevalence of metabolic syndrome and cardiometabolic risks is unclear. The present study is conducted to investigate the relationship between serum uric acid and the prevalence metabolic syndrome and left ventricular hypertrophy.

Conditions

  • Hyperuricemia
  • Healthy

Interventions

DIAGNOSTIC_TEST

Hyperuricemia

Hyperuricemia vs. normouricemia

Sponsors & Collaborators

  • National Defense Medical Center, Taiwan

    lead OTHER

Eligibility

Min Age
20 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-03-26
Primary Completion
2020-12-31
Completion
2020-12-31

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03473951 on ClinicalTrials.gov